Status:
NOT_YET_RECRUITING
Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3
Lead Sponsor:
Temple University
Collaborating Sponsors:
Cooperman Barnabas Medical Center
Conditions:
Kidney Disease, Chronic
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to understand the communication occurring between Black and Caucasian patients and their transplant providers during transplant evaluation consultations and assess r...
Detailed Description
Live donor kidney transplant (LDKT) is the preferred treatment modality for patients with chronic and end-stage kidney disease. LDKT is less expensive than prolonged dialysis and offers improved morta...
Eligibility Criteria
Inclusion
- (1) appear for a kidney transplant evaluation at Cooperman Barnabas Medical Center (CBMC) or Temple University Hospital (TUH)
- (2) speak English
- (3) be of self-reported Black or Caucasian ethnicity
- (4) be ≥18 years of age.
- Including patients who:
- have received prior kidney transplants
- patients with limited English proficiency, as long as they speak with the physician via a translator
- patients evaluated at offsite satellite locations that are not actually at CBMC or TUHS.
- All transplant nephrologists, nurses, and social workers employed at the kidney transplant programs at CBMC and TUH who are actively involved in patient evaluations for transplant will be eligible for participation in the study. Providers refusing to permit digital audio recording of the transplant consultation will be deemed ineligible.
Exclusion
- (1) are non-verbal or otherwise unable to converse with providers
- (2) are already listed for kidney transplant at CBMC or TUHS or at another transplant center
- (3) have limited English proficiency and speak directly with the physician in a language other than English.
- Patients having (1) received an offer to donate a kidney from a family member or friend, or (2) explicitly asked a family member or friend to consider serving as a LD will be excluded, along with any patients refusing to permit digital audio recording of the transplant consultation will also be deemed ineligible to participate.
- The following special populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), prisoners, and individuals who do not understand English.
- It is unlikely that any female patient will be pregnant while awaiting kidney transplant; however, we will not exclude pregnant women.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06182475
Start Date
January 1 2026
End Date
May 1 2027
Last Update
July 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cooperman Barnabas Medical Center
Livingston, New Jersey, United States, 07039
2
Temple University
Philadelphia, Pennsylvania, United States, 19122